Reagents and Chemicals
Affi-Gel 15
Trypsin
Trypsin inhibitor Yeast extract
Hydroxyapatite Nutrient broth Sephacryl S-300 TRITC-anti rabbit IgG
Agar Noble CM-Sepahdex A-50
Materials
Cooked meat medium
DEAE-Sepahdex A-50 Ficoll 400
Supplier
Bio-Rad
Difco laboratoires
Pharmacia
Difco Laboratories
Pharmacia
Pharmacia
Bio-Rad
Difco Laboratories
Pharmacia
Biosource
International
(Tago Products)
Sigma
Sigma
Difco Laboratories
T 7409 T 9003 527-00305
153-6051
526-00054
17-0220-01
529-00804
17-0180-01
17-0400-01
157-0080
523-00483
17-0599-01
ALI-4406
Cat-No.
References
Bengston IA (1922): Preliminary note on a toxin-producing anaerobe isolated from the larvae of Lucilia caesar. Public Health Rep. 37: 164-170.
Iwasaki M, Ohishi I, Sakaguchi G (1980): Evidence that botulinum C2 toxin has two dissimilar components. Infect. Immun. 29: 390-394.
Jansen BC (1971): The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J. Vet. Res. 38: 93-98.
Mason JH, Robinson EM (1935): The antigenic components of the toxins of C. botulinum types C and D. Onderstepoort J. Vet. Sei. Anim. Indus. 5: 65-75.
Miyake M, Ohishi I (1987): Reponse of tissue-cultured cynomolgus monkey kidney cells to botulinum C2 toxin. Microbial Pathogenesis, 3: 279-286.
Ohishi I, Iwasaki M, Sakaguchi G (1980): Purification and characterization of two components of botulinum C2 toxin. Infect. Immun. 30: 668-673.
Ohishi I, Iwasaki M, Sakaguchi G (1980): Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components. Infect. Immun. 31: 890-895.
Ohishi I, Sakaguchi G (1982): Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity. Infect. Immun.
Ohishi I (1983): Response of mouse intestinal loop to botulinum C2 toxin: en-terotoxic activity induced by cooperation of nonlinked protein components. Infect, immun. 40: 691-695.
Ohishi I, Tsuyama S (1986): ADP-ribosylation of nonmuscle actin with component I of C2 toxin. Biochem. Biophys. Res. Commun. 136: 802-806.
Ohishi I (1986): NAD-glycohydrolase activity of botulinum C2 toxin: a possible role of component I in the mode of action of the toxin. J. Biochem. 100: 407-413.
Ohishi I (1987): Activation of botulinum C2 toxin by trypsin. Infect. Immun. 55: 1461-1465.
Ohishi I, Morikawa Y, Baba T (1990): ADP-ribosylation of nonmuscle actin by component I of botulinum C2 toxin inactivates the ability to interact with unmodified actin. J. Biochem. 107: 420-425.
Ohishi I (1992): Visualizations of binding and internalization of two nonlinked protein components of botulinum C2 toxin in tissue culture cells. 60: 4648-4655.
Bacterial Toxins
Kletus AKtories
Copyright © 2002 WILEY-VCH Verlag GmbH & Co. KGaA
Anti Aging Made Easy
When it comes to reducing wrinkles, you really have to take your needs seriously. There are a number of factors that play a role in the health and well being of your skin. It is often hard to understand how products work and why they may not work even if they promise to do so. If you are considering wrinkle creams and a regimen of facelifts, you may go broke in the process. Before you do all of that, consider going through a process of determine the very best solution for your needs.
Post a comment